COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Tharimmune is a clinical-stage biotechnology company that is branching into digital assets by acquiring Canton Coin and operating as a Super Validator on the Canton Network blockchain.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
